Literature DB >> 14978344

ATP- and adenosine-mediated signaling in the central nervous system: adenosine stimulates glutamate release from astrocytes via A2a adenosine receptors.

Tomoyuki Nishizaki1.   

Abstract

Adenosine enhanced intracellular Ca(2+) concentrations in astrocytes via A(2a) adenosine receptors involving protein kinase A (PKA) activation. The Ca(2+) rise is inhibited by brefeldin A, an inhibitor of vesicular transport; but not by neomycin and U73122, phospholipase C inhibitors; xestospongin, an IP(3)-receptor inhibitor; ryanodine, a ryanodine-receptor inhibitor; TMB-8, an endoplasmic reticulum calcium-release blocker; octanol, a gap-junction inhibitor; or cadmium, a non-selective, calcium-channel blocker. Adenosine stimulates astrocytic glutamate release via an A(2a) adenosine receptors/PKA pathway, and the release is inhibited by the vesicular transport inhibitors brefeldin A and bafilomycin A1. A(2a) adenosine receptors and the ensuing PKA events, thus, are endowed with vesicular Ca(2+) release from an unknown intracellular calcium store and vesicular glutamate release from astrocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978344     DOI: 10.1254/jphs.94.100

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  16 in total

1.  Long-term proline exposure alters nucleotide catabolism and ectonucleotidase gene expression in zebrafish brain.

Authors:  Luiz Eduardo Baggio Savio; Fernanda Cenci Vuaden; Denis B Rosemberg; Maurício R Bogo; Carla Denise Bonan; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2012-06-07       Impact factor: 3.584

2.  Effects of hypoxia, glucose deprivation and recovery on the expression of nucleoside transporters and adenosine uptake in primary culture of rat cortical astrocytes.

Authors:  Zoran B Redzic; Slava A Malatiali; Maie Al-Bader; Hameed Al-Sarraf
Journal:  Neurochem Res       Date:  2010-06-25       Impact factor: 3.996

Review 3.  Caffeine and the control of cerebral hemodynamics.

Authors:  Dale A Pelligrino; Hao-Liang Xu; Francesco Vetri
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.

Authors:  K Xu; D G Di Luca; M Orrú; Y Xu; J-F Chen; M A Schwarzschild
Journal:  Neuroscience       Date:  2016-02-22       Impact factor: 3.590

5.  Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Authors:  Attila Köfalvi; Ricardo J Rodrigues; Catherine Ledent; Ken Mackie; E Sylvester Vizi; Rodrigo A Cunha; Beáta Sperlágh
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

6.  Calcium increases in retinal glial cells evoked by light-induced neuronal activity.

Authors:  Eric A Newman
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.167

Review 7.  Pathophysiological roles for purines: adenosine, caffeine and urate.

Authors:  Micaela Morelli; Anna R Carta; Anil Kachroo; Michael A Schwarzschild
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 8.  Purinergic signaling and energy homeostasis in psychiatric disorders.

Authors:  D Lindberg; D Shan; J Ayers-Ringler; A Oliveros; J Benitez; M Prieto; R McCullumsmith; D-S Choi
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

9.  Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.

Authors:  Anna R Carta; Anil Kachroo; Nicoletta Schintu; Kui Xu; Michael A Schwarzschild; Jadwiga Wardas; Micaela Morelli
Journal:  J Neurochem       Date:  2009-10-08       Impact factor: 5.372

Review 10.  From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Authors:  Vanessa Flaten; Cyril Laurent; Joana E Coelho; Ursula Sandau; Vânia L Batalha; Sylvie Burnouf; Malika Hamdane; Sandrine Humez; Detlev Boison; Luísa V Lopes; Luc Buée; David Blum
Journal:  Biochem Soc Trans       Date:  2014-04       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.